Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis.

Front Oncol · 2022 · PMC9425065 · PMID 36052255

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Moreover, high PD-L1 expression in patients with EGFR-mutant NSCLC showed a trend toward better outcomes than those with low PD-L1 expression ( 57 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.